74 related articles for article (PubMed ID: 1539257)
1. In vitro assessment of triple-therapy immunosuppression and prostaglandin analogues enisoprost and misoprostol.
Hibbins M; Chapman JR
Transplant Proc; 1992 Feb; 24(1):224-6. PubMed ID: 1539257
[No Abstract] [Full Text] [Related]
2. The effect of the prostaglandin analogues misoprostil and enisoprost on the synergy between donor-specific transfusion and cyclosporine in allograft survival.
Cofer BR; Davies CB; Alexander JW; Tchervenkov JI
Transplantation; 1992 Nov; 54(5):941-3. PubMed ID: 1440866
[No Abstract] [Full Text] [Related]
3. Immune modifying effects of misoprostol and natural prostaglandins.
Iyengar S; Contreras PC; Mick SJ; Bremer ME; McKearn JP
Br J Rheumatol; 1991; 30 Suppl 2():71-4. PubMed ID: 1899625
[TBL] [Abstract][Full Text] [Related]
4. Prostaglandin E1 analogues misoprostol and enisoprost decrease microbial translocation and modulate the immune response.
Gianotti L; Alexander JW; Pyles T; Fukushima R; Babcock GF
Circ Shock; 1993 Aug; 40(4):243-9. PubMed ID: 8375025
[TBL] [Abstract][Full Text] [Related]
5. UVB irradiation of human-derived peripheral blood lymphocytes induces apoptosis but not T-cell anergy: additive effects with various immunosuppressive agents.
Yaron I; Yaron R; Oluwole SF; Hardy MA
Cell Immunol; 1996 Mar; 168(2):258-66. PubMed ID: 8640873
[TBL] [Abstract][Full Text] [Related]
6. Triple drug immunosuppression significantly reduces immune activation and allograft arteriosclerosis in cytomegalovirus-infected rat aortic allografts and induces early latency of viral infection.
Lemström KB; Bruning JH; Bruggeman CA; Lautenschlager IT; Häyry PJ
Am J Pathol; 1994 Jun; 144(6):1334-47. PubMed ID: 8203471
[TBL] [Abstract][Full Text] [Related]
7. In vitro response to immunosuppressive agents in blacks.
Ward M; Lazda VA; Gaddis PJ; Stormoen BM; Smith Y; Fabrega AJ; Pollak R
Transplant Proc; 1993 Aug; 25(4):2470-1. PubMed ID: 8356636
[No Abstract] [Full Text] [Related]
8. Role of a prostaglandin E1 analogue in the prevention of acute graft rejection by cyclosporine.
N Engl J Med; 1990 Sep; 323(12):831-3. PubMed ID: 2118233
[No Abstract] [Full Text] [Related]
9. Prostaglandin E1 and E2 suppression of in vitro lymphoid responses to alloantigen.
Bowes LG; Dumble LJ; Pollak R; Ruwart MJ; Francis DM; Hunter S; Clunie GJ
Transplant Proc; 1989 Oct; 21(5):3769-70. PubMed ID: 2530676
[No Abstract] [Full Text] [Related]
10. The immunosuppressive properties of new oral prostaglandin E1 analogs.
Pollak R; Dumble LJ; Wiederkehr JC; Maddux MS; Moran M
Transplantation; 1990 Nov; 50(5):834-8. PubMed ID: 2146785
[TBL] [Abstract][Full Text] [Related]
11. Preferential binding of the novel prostaglandin SC-46275 to canine gastric versus intestinal receptors.
Tsai BS; Keith RH; Perkins WE; Walsh RE; Anglin CP; Collins PW; Gasiecki AW; Bauer RF; Jones PH; Gaginella TS
J Pharmacol Exp Ther; 1995 Oct; 275(1):368-73. PubMed ID: 7562572
[TBL] [Abstract][Full Text] [Related]
12. Prolongation of rat heart allograft survival using cyclosporine and enisoprost, a prostaglandin E1 analog.
Fabrega AJ; Blanchard J; Rivas PA; Moran SM; Pollak R
Transplantation; 1992 Jun; 53(6):1363-4. PubMed ID: 1604492
[No Abstract] [Full Text] [Related]
13. Effects on in vivo and in vitro hepatocyte proliferation of methylprednisolone, azathioprine, mycophenolic acid, mizoribine, and prostaglandin E1.
Azzarone A; Francavilla A; Carrieri G; Gasbarrini A; Scotti-Foglieni C; Fagiuoli S; Cillo U; Zeng QH; Starzl TE
Transplant Proc; 1992 Dec; 24(6):2868-71. PubMed ID: 1465977
[No Abstract] [Full Text] [Related]
14. Profibrotic cytokines and lymphocyte proliferation in stable renal allograft recipients treated with or without cyclosporine A.
Waiser J; Schneider M; Eljazyfer S; Slowinski T; Glander P; Einecke G; Budde K; Neumayer HH; Böhler T
Clin Immunol; 2006 Apr; 119(1):59-66. PubMed ID: 16451828
[TBL] [Abstract][Full Text] [Related]
15. Prostaglandin E1 and misoprostol increase epidermal growth factor production in 3D-cultured human annulus cells.
Gruber HE; Hoelscher G; Loeffler B; Chow Y; Ingram JA; Halligan W; Hanley EN
Spine J; 2009 Sep; 9(9):760-6. PubMed ID: 19535298
[TBL] [Abstract][Full Text] [Related]
16. Synergism in immunosuppression. I. Effect of methylprednisolone, azathioprine, chlorambucil, and radiation on tetanus antitoxin production.
Friedman EA; Gelfand M; Bernheimer HP
Transplantation; 1971 May; 11(5):479-86. PubMed ID: 5089511
[No Abstract] [Full Text] [Related]
17. Computerized quantitation of immunosuppressive synergy for clinical protocol design.
Chou TC; Stepkowski SM; Kahan BD
Transplant Proc; 1994 Oct; 26(5):3043-5. PubMed ID: 7940955
[No Abstract] [Full Text] [Related]
18. Immunosuppressant pharmacodynamics on lymphocytes from healthy subjects and patients with chronic renal failure, nephrosis, and psoriasis: possible implications for individual therapeutic efficacy.
Hirano T; Oka K; Takeuchi H; Kozaki K; Matsuno N; Nagao T; Kozaki M; Ichikawa M; Yoshida M; Umezawa Y; Hirata M; Oh-i T; Koga M
Clin Pharmacol Ther; 1997 Dec; 62(6):652-64. PubMed ID: 9433394
[TBL] [Abstract][Full Text] [Related]
19. Analysis of the interactions of immunosuppressive drugs with cyclosporine in inhibiting DNA proliferation.
Vathsala A; Chou TC; Kahan BD
Transplantation; 1990 Feb; 49(2):463-72. PubMed ID: 1689520
[TBL] [Abstract][Full Text] [Related]
20. Immunosuppressive effect of misoprostol: a new synthetic prostaglandin E1 analogue.
Wiederkehr JC; Dumble L; Pollak R; Moran M
Aust N Z J Surg; 1990 Feb; 60(2):121-4. PubMed ID: 2109591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
